Literature DB >> 16872921

Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation.

Peter Verheesen1, Andreas Roussis, Hans J de Haard, Arjan J Groot, Jord C Stam, Johan T den Dunnen, Rune R Frants, Arie J Verkleij, C Theo Verrips, Silvère M van der Maarel.   

Abstract

With the completion of the sequence of the human genome, emphasis is now switching to the human proteome. However, the number of proteins is not only larger than mRNAs in the transcriptome, proteins need often to be in complex with other proteins to be functional. A favourable option to study proteins in their natural context is with a combination of biochemical and microscopic techniques using specific antibodies. Therefore, we designed a fast, reliable and controllable selection and screening of single-domain antibody fragments (VHH) from a Camelid non-immune library. We isolated VHH for four muscle disease related proteins; emerin, actin, tropomyosin-1, and nuclear poly(A)-binding protein. Important features of antibodies for target validation studies are recognition of the antigen in natural conformations and biologically relevant complexes. We show that selected antibody fragments are functional in various immunological techniques and prove useful in diagnostic applications. Our selection strategy is amenable to automation and to the establishment of proteomics platforms. It opens the way to quickly and cost-effectively obtain multiple antibody fragments for many antigens that can detect changes in their localization, level, and modification as well as subtle changes in supramolecular structures, which often associate with disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872921     DOI: 10.1016/j.bbapap.2006.05.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

1.  A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.

Authors:  Mahtab Moayeri; Clinton E Leysath; Jacqueline M Tremblay; Catherine Vrentas; Devorah Crown; Stephen H Leppla; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

2.  Diagnostic evaluation of a nanobody with picomolar affinity toward the protease RgpB from Porphyromonas gingivalis.

Authors:  Peter Durand Skottrup; Paul Leonard; Jakub Zbigniew Kaczmarek; Florian Veillard; Jan Johannes Enghild; Richard O'Kennedy; Aneta Sroka; Rasmus Prætorius Clausen; Jan Potempa; Erik Riise
Journal:  Anal Biochem       Date:  2011-04-20       Impact factor: 3.365

Review 3.  Single domain antibodies for the knockdown of cytosolic and nuclear proteins.

Authors:  Thomas Böldicke
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

4.  A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.

Authors:  Davide Ferrari; Valentina Garrapa; Massimo Locatelli; Angelo Bolchi
Journal:  Mol Biotechnol       Date:  2020-01       Impact factor: 2.695

5.  Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function.

Authors:  Christophe Blanchetot; Dennis Verzijl; Azra Mujić-Delić; Leontien Bosch; Louise Rem; Rob Leurs; C Theo Verrips; Michael Saunders; Hans de Haard; Martine J Smit
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

6.  Arginine methylation of the nuclear poly(a) binding protein weakens the interaction with its nuclear import receptor, transportin.

Authors:  Katharina Fronz; Stefan Güttinger; Kerstin Burkert; Uwe Kühn; Nadine Stöhr; Angelika Schierhorn; Elmar Wahle
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

7.  Analysis and modeling of the variable region of camelid single-domain antibodies.

Authors:  Aroop Sircar; Kayode A Sanni; Jiye Shi; Jeffrey J Gray
Journal:  J Immunol       Date:  2011-04-27       Impact factor: 5.422

8.  Differential recognition of vascular and parenchymal beta amyloid deposition.

Authors:  Kim S Rutgers; Alexandra van Remoortere; Mark A van Buchem; C Theo Verrips; Steven M Greenberg; Brian J Bacskai; Matthew P Frosch; Sjoerd G van Duinen; Marion L Maat-Schieman; Silvère M van der Maarel
Journal:  Neurobiol Aging       Date:  2009-12-16       Impact factor: 4.673

9.  Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.

Authors:  Kasper Krogh Andersen; Nika M Strokappe; Anna Hultberg; Kai Truusalu; Imbi Smidt; Raik-Hiio Mikelsaar; Marika Mikelsaar; Theo Verrips; Lennart Hammarström; Harold Marcotte
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

10.  Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).

Authors:  David R Maass; Jorge Sepulveda; Anton Pernthaner; Charles B Shoemaker
Journal:  J Immunol Methods       Date:  2007-05-15       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.